Within the newest buying and selling session, Valero Vitality (VLO) closed at $178.27, marking a -1.27% transfer from yesterday. The inventory fell in need of the S&P 500, which registered a acquire of 0.62% for the day. Elsewhere, the Dow gained 0.99%, whereas the tech-heavy Nasdaq added 0.65%.
Shares of the oil refiner witnessed a acquire of 4.04% over the earlier month, beating the efficiency of the Oils-Vitality sector with its acquire of 0.26%, and the S&P 500’s acquire of 0.59%.
The funding group will likely be carefully monitoring the efficiency of Valero Vitality in its forthcoming earnings report. The corporate is scheduled to launch its earnings on January 29, 2026. The corporate is predicted to put up an EPS of $3.1, indicating a 384.38% progress in comparison with the equal quarter final yr. On the similar time, our most up-to-date consensus estimate is projecting a income of $29.03 billion, reflecting a 5.62% fall from the equal quarter final yr.
VLO’s full-year Zacks Consensus Estimates are calling for earnings of $9.97 per share and income of $121.67 billion. These outcomes would characterize year-over-year modifications of +17.57% and 0%, respectively.
Traders also needs to take note of any newest modifications in analyst estimates for Valero Vitality. These revisions assist to point out the ever-changing nature of near-term enterprise tendencies. Therefore, constructive alterations in estimates signify analyst optimism relating to the enterprise and profitability.
Our analysis demonstrates that these changes in estimates immediately affiliate with imminent inventory worth efficiency. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate modifications into consideration and delivers a transparent, actionable score mannequin.
The Zacks Rank system, which varies between #1 (Robust Purchase) and #5 (Robust Promote), carries a powerful monitor file of exceeding expectations, confirmed by exterior audits, with shares at #1 delivering a mean annual return of +25% since 1988. Over the previous month, the Zacks Consensus EPS estimate has moved 1.26% decrease. Valero Vitality is holding a Zacks Rank of #3 (Maintain) proper now.
Taking a look at valuation, Valero Vitality is presently buying and selling at a Ahead P/E ratio of 14.46. This means a premium in distinction to its business’s Ahead P/E of 11.86.
Additionally, we should always point out that VLO has a PEG ratio of 1.03. The PEG ratio is akin to the generally utilized P/E ratio, however this measure additionally incorporates the corporate’s anticipated earnings progress price. As of the shut of commerce yesterday, the Oil and Fuel – Refining and Advertising business held a mean PEG ratio of 1.03.
The Oil and Fuel – Refining and Advertising business is a part of the Oils-Vitality sector. This business, at present bearing a Zacks Trade Rank of 99, finds itself within the prime 41% echelons of all 250+ industries.
The Zacks Trade Rank evaluates the facility of our distinct business teams by figuring out the common Zacks Rank of the person shares forming the teams. Our analysis exhibits that the highest 50% rated industries outperform the underside half by an element of two to 1.
Consider to depend on Zacks.com to look at all these stock-impacting metrics, and extra, within the succeeding buying and selling classes.
Simply Launched: Zacks High 10 Shares for 2026
Hurry – you’ll be able to nonetheless get in early on our 10 prime tickers for 2026. Handpicked by Zacks Director of Analysis Sheraz Mian, this portfolio has been stunningly and constantly profitable.
From inception in 2012 via November, 2025, the Zacks High 10 Shares gained +2,530.8%, greater than QUADRUPLING the S&P 500’s +570.3%.
Sheraz has combed via 4,400 corporations coated by the Zacks Rank and handpicked one of the best 10 to purchase and maintain in 2026. You possibly can nonetheless be among the many first to see these just-released shares with huge potential.
Valero Vitality Company (VLO) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.
